TM3
Carcinoembryonic antigen, Neuron Specific enolase, Cytokeratin 19 Fragment detection Kit (Flow fluorescence luminescence)
Recently, the “carcinoembryonic antigen, neuron specific enolase, Cytokeratin 19 Fragment Detection Kit (Flow fluorescence luminescence)” (referred to as “TM3”) independently developed by Shanghai Wonzigene Biotechnology Co., Ltd. has been approved by Shanghai Municipal Drug Administration to go on the market!
Shanghai Wonzigene Biotechnology Co., Ltd. was established in April 2021 with a registered capital of 100 million yuan. It is a wholly owned subsidiary of Zhejiang Oriental Gene Biological Products Co., LTD. (hereinafter referred to as “Oriental Biological”, stock code 688298).
In order to meet the requirements of domestic medical and health work policies and clinical laboratory technology development, Shanghai Wonzigene Biotechnology Co., LTD., on the basis of digesting and absorbing the introduced flow fluorescence luminescence technology, has applied quantum dot coding microsphere technology, single laser technology, high-speed digital signal processing technology, fluid science, automation, and innovation research to develop a new automatic high-throughput flow fluorescence luminescence (also known as liquid chip, suspension array) technology and platform. With all core intellectual property rights, it can be widely used in immunoassay, nucleic acid detection, enzymology, receptor and ligand recognition and other fields.
Liquid chip has the advantages of high sensitivity, fast reaction speed, high throughput, good repeatability, simple operation, small amount of sample, good flexibility and low cost.
The company focuses on the innovation and development of in-vitro diagnostic reagents in the liquid chip field, and strives to become an outstanding innovator and leader in this technology field.
From the coding microsphere technology, professional testing instruments, fully automated testing platform, rich and complete products, fast and efficient service system and other aspects of wholeheartedly serve the majority of users, to achieve customer value enhancement!
